Vincerx Pharma, Inc.
VINC · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,000 | -$7,994 | -$7,843 | -$1,808 |
| Dep. & Amort. | $0 | $281 | $275 | $270 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $435 | $610 | $1,423 | $912 |
| Change in WC | -$1,619 | $1,454 | -$451 | $125 |
| Other Non-Cash | $1,730 | -$532 | $217 | -$5,327 |
| Operating Cash Flow | -$4,454 | -$6,181 | -$6,379 | -$5,828 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$3,126 | -$8,337 |
| Inv. Sales/Matur. | $0 | $7,175 | $4,500 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $7,175 | $1,374 | -$8,337 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $3,856 | $961 | -$16,913 | $16,913 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $24 | $0 | $89 |
| Financing Cash Flow | $3,856 | $985 | $0 | $17,002 |
| Forex Effect | $51 | $60 | $27 | -$24 |
| Net Chg. in Cash | -$547 | $2,039 | -$4,978 | $2,813 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,066 | $3,027 | $8,005 | $5,192 |
| End Cash | $4,519 | $5,066 | $3,027 | $8,005 |
| Free Cash Flow | -$4,454 | -$6,181 | -$6,379 | -$5,828 |